Novel biomarker panel predicts prognosis in HPV-negative oropharyngeal cancer: An analysis of the TAX 324 trial (WU)

PURPOSE: New treatment strategies for locally-advanced HNSCC combine induction chemotherapy and chemoradiation. Identifying predictors of outcome for sequentially-treated patients is critical for focusing therapeutic research. In this analysis, we evaluated HPV-16 status as well as expression of a d...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer
Egile Nagusiak: Wu, Yin, Posner, Marshall R., Schumaker, Lisa M., Nikitakis, Nikolaos, Goloubeva, Olga, Tan, Ming, Lu, Changwan, Iqbal, Sana, Lorch, Jochen, Sarlis, Nicholas J., Haddad, Robert I., Cullen, Kevin J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4358790/
https://ncbi.nlm.nih.gov/pubmed/22009819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26485
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak